Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street

Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street

Israel "Izzy" Englander's hedge fund, Millennium Management, shows a strong interest in tech stocks along with a recent investment in Eli Lilly. Despite competition concerns, Wall Street remains bullish on Lilly, expecting a 19% upside due to promising drug sales and potential growth.

Read More

Did you find this insightful?